Clover Biopharmaceuticals Ltd (2197.HK)
|Gross Profit (TTM)||-HK$475.64M|
|Year Range||HK$1.12 - HK$6.09|
Share Price Chart
The chart shows the growth of an initial investment of HK$10,000 in Clover Biopharmaceuticals Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Clover Biopharmaceuticals Ltd had a return of -56.37% year-to-date (YTD) and -71.32% in the last 12 months. Over the past 10 years, Clover Biopharmaceuticals Ltd had an annualized return of -79.77%, outperforming the S&P 500 benchmark which had an annualized return of -7.44%.
|5 years (annualized)||-79.77%||-7.44%|
|10 years (annualized)||-79.77%||-7.44%|
Monthly Returns Heatmap
This table presents a comparison of risk-adjusted performance metrics for Clover Biopharmaceuticals Ltd (2197.HK) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
|Sharpe ratio||Sortino ratio||Omega ratio||Calmar ratio||Ulcer Index|
|Clover Biopharmaceuticals Ltd||-0.74|
The Drawdowns chart displays portfolio losses from any high point along the way.
The table below shows the maximum drawdowns of the Clover Biopharmaceuticals Ltd. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Clover Biopharmaceuticals Ltd is 92.03%, recorded on Jun 1, 2023. The portfolio has not recovered from it yet.
|-92.03%||Dec 14, 2021||359||Jun 1, 2023||—||—||—|
|-29.97%||Nov 8, 2021||3||Nov 10, 2021||21||Dec 9, 2021||24|
The current Clover Biopharmaceuticals Ltd volatility is 22.62%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.